Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Emily Leproust
Age : 48
Public asset : 15,435,494 USD
Country of residence : Unknown
Linked companies : Twist Bioscience Corporation - Sema4 Holdings Corp.

Biography of Emily Leproust 
Emily Marine Leproust founded Twist Bioscience Corp. and Petri. Dr. Leproust holds the position of Chairman, President & Chief Executive Officer for Twist Bioscience Corp. She is also on the board of CM Life Sciences, Inc. Dr. Leproust previously was Chairman at Nektar Therapeutics and Director-Applications & Chemistry at Agilent Technologies, Inc. Dr. Leproust received a doctorate from the University of Houston and a graduate degree from Lyon School of Industrial Chemistry.


Current positions of Emily Leproust 
Holdings of Emily Leproust 
Emily Leproust : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
08:14aELON MUSK : human-like robots and self-driving cars
RE
01:41pBERNARD ARNAULT : LVMH has pricing power to counter inflation, but must be reasonable-Arnault
RE
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/26WILLIAM ACKMAN : Ackman's Pershing Square takes new position in Netflix
RE
01/25JOHN HESS : Hess Corp sees higher capital spending, production in 2022
RE
More news


© 2022 People and Ownership :   
Emily Leproust : Connections 


Latest news about Emily Leproust 
2021Twist Bioscience Reports Widened Fiscal Fourth-Quarter Loss as Revenue Rises; Plans to Buy Abveris for Up to $190 Million
MT
2021Mount Sinai Genomics, Inc. completed the acquisition of CM Life Sciences, Inc. from CMLS Holdings LLC, Eli D. Casdin, Keith A. Meister and others in a reverse merger transaction.
CI
2021TWIST BIOSCIENCE : to Acquire Custom-Designed Antibody Library and Optimization Software
MT
2021TWIST BIOSCIENCE : Reports Positive Data From GLP-1R Antibodies Study
MT
2021Mount Sinai Genomics, Inc. signed a letter of intent to acquire CM Life Sciences, Inc. from CMLS Holdings LLC, Eli D. Casdin, Keith A. Meister and others for $2.4 billion in a reverse merger transaction.
CI
2020CM Life Sciences, Inc. Announces Board Appointment
CI
2020CM Life Sciences, Inc. announced that it has received $10.855001 million in funding from CMLS Holdings LLC, and other investors
CI
More news